School of Public Health, Hebei United University, Tangshan, Hebei, China.
IUBMB Life. 2012 Jul;64(7):617-27. doi: 10.1002/iub.1027. Epub 2012 May 31.
Lp was a generally recognized as safe microorganism. Lactobacillus plantarum 590 was obtained by inserting nisI gene into Lp genome to help it tolerate higher concentration nisin. As the unintended effects of the genetically modified microorganism (GMM) are the most important barriers to the progress of GMM, we have performed a useful exploration to establish a new in vivo evaluation model for GMM from the point of view of intestinal health. In this study, Sprague-Dawley rats were orally administered with Lp 590 and Lp for 4 weeks. Fecal samples were collected to determine the number of beneficial bacteria Bifidobacterium and harmful bacteria Clostridium perfringens. Denaturing gradient gel electrophoresis was used to detect the bacterial profiles of every group. Fecal enzyme activities and short-chain fatty acids as main metabolites were also examined. Real time PCR (RT-PCR) and immunohistochemistry were used to analyze two proteins (ZO-1 and occludin) and secretory immunoglobulin A to detect intestinal permeability and mucosal immunity, gut permeability and gut mucosal immunity were analyzed to see whether GM Lp 590 can induce changes of the gut health when compared with non-GM Lp group, andeventually we concluded that there is no significant difference between GM Lp 590-fed group and non-GM Lp-fed group. The conclusion of gut health test was comparable withthat from traditional subchronic test. Evaluation of intestinal health will be a new approach of assessing the safety of GMM.
Lp 被普遍认为是安全的微生物。通过将 nisI 基因插入 Lp 基因组中,获得了植物乳杆菌 590,以帮助其耐受更高浓度的乳链菌肽。由于遗传修饰微生物(GMM)的意外影响是 GMM 发展的最重要障碍,因此,我们从肠道健康的角度出发,对建立 GMM 的新体内评估模型进行了有益的探索。在这项研究中,Sprague-Dawley 大鼠经口给予 Lp590 和 Lp 4 周。收集粪便样本以确定有益细菌双歧杆菌和有害细菌产气荚膜梭菌的数量。变性梯度凝胶电泳用于检测每组的细菌图谱。还检查了粪便酶活性和短链脂肪酸作为主要代谢物。实时 PCR(RT-PCR)和免疫组织化学用于分析两种蛋白质(ZO-1 和 occludin)和分泌型免疫球蛋白 A,以检测肠道通透性和黏膜免疫,分析肠道通透性和肠道黏膜免疫,以观察 GM Lp590 是否会在与非 GM Lp 组相比时引起肠道健康的变化,最终我们得出结论,GM Lp590 喂养组与非 GM Lp 喂养组之间没有显著差异。肠道健康测试的结论与传统亚慢性测试的结论相当。肠道健康评估将成为评估 GMM 安全性的新方法。